Revista Panamericana de Salud Pública/Pan American Journal of Public Health (RPSP/PAJPH) – August 2015 Vol. 38, No. 2

Revista Panamericana de Salud Pública/Pan American Journal of Public Health (RPSP/PAJPH)
August 2015 Vol. 38, No. 2
http://www.paho.org/journal/

.
SERIES ON EQUITY IN HEALTH AND SUSTAINABLE DEVELOPMENT
Desigualdades educacionales en mortalidad y supervivencia de mujeres y hombres de las Américas, 1990–2010 [Educational inequalities in mortality and survival of women and men in the Americas, 1990–2010]
Mariana Haeberer, Isabel Noguer y Oscar J. Mújica

Assessing equitable care for Indigenous and Afrodescendant women in Latin America
[Evaluación de la equitatividad de la atención a las mujeres indígenas y afrodescendientes de América Latina]
Arachu Castro, Virginia Savage, and Hannah Kaufman

ORIGINAL RESEARCH ARTICLES
Formative evaluation of a proposed mHealth program for childhood illness management in a resource-limited setting in Peru [Evaluación formativa de un programa de salud móvil propuesto para el manejo de las enfermedades de la infancia en un entorno del Perú con recursos limitados]
T. A. Calderón, H. Martin, K. Volpicelli, C. Diaz, E. Gozzer, and A. M. Buttenheim

CURRENT TOPICS
Paving pathways: Brazil’s implementation of a national human papillomavirus immunization campaign [Allanando el camino: implementación de una campaña nacional de vacunación contra el virus del papiloma humano en Brasil]
Misha L. Baker, Daniella Figueroa-Downing, Ellen Dias De Oliveira Chiang,
Luisa Villa, Maria Luiza Baggio, José Eluf-Neto, Robert A. Bednarczyk, and Dabney P. Evans
Abstract
In 2014, Brazil introduced an HPV immunization program for girls 9–13 years of age as part of the Unified Health System’s (SUS) National Immunization Program. The first doses were administered in March 2014; the second ones, in September 2014. In less than 3 months more than 3 million girls received the first dose of quadrivalent HPV vaccine, surpassing the target rate of 80%. This paper examines three elements that may influence the program’s long-term success in Brazil: sustaining effective outreach, managing a large technology-transfer collaboration, and developing an electronic immunization registry, with a focus on the State of São Paulo. If these three factors are managed, the Government of Brazil is primed to serve as a model of success for other countries interested in implementing a national HPV vaccination program to decrease HPV-related morbidity and mortality.